BioCentury Innovations Fact Sheet

Your resource for innovations in translational drug development
BioCentury Innovations is a weekly publication covering developments in translational research
that provides knowledgeable perspectives on the key innovations, trends and opportunities in
early drug development. In addition, BioCentury Innovations contains timely, concise and
understandable analysis of the scientific content and commercial potential of the most important
translational research papers from across the life science literature.
Together with the flagship publication BioCentury, BioCentury Innovations offers a comprehensive
source of value-added information for the full path of a product from idea to IND.
For CEOs, CSOs, CMOs and other corporate
executives, BioCentury Innovations will:
• Identify “white space” opportunities and
emerging trends to help guide investment
decisions and resource allocation
• Identify and analyze important regulatory and
policy developments about scientific advances
that influence translational medicine
• Provide analysis of company strategies for
advancing preclinical compounds into the clinic
Each year, BioCentury Innovations highlights:
• More than 1000 different companies and
academic institutions
• More than 2500 unique targets with
commercial potential
• More than 600 unique preclinical
compounds
For VCs, investment professionals and business
development specialists, BioCentury Innovations will:
• Save time and resources by identifying and
describing emerging science and technology
with commercial potential
• Facilitate early opportunities for investment,
alliances and partnerships
• Identify novel competition
• Lower investment risk
For scientists in pharma, biotechs and academia,
BioCentury Innovations will:
• Identify and describe the key translational research
papers that cover innovations from idea to IND
• Provide important scientific and commercial
perspectives on emerging technologies and
opportunities in discovery research
SUBSCRIBE TO BIOCENTURY INNOVATIONS TODAY
See how you can leverage BioCentury to tap into the latest in translational drug development.
+1 650-595-5333 x202
[email protected]
www.biocentury.com
BioCentury®; The BioCentury 100™; The Clear Route to ROI™, Because Real Intelligence is Hard to Find™, BCIQ™, BioPharma’s Knowledge Center™ and BioCentury Innovations™
are trademarks of BIOCENTURY PUBLICATIONS, INC. Copyright© 2015 ALL RIGHTS RESERVED.
Inside BioCentury Innovations
• Published weekly to BioCentury.com for institutional access and as a downloadable PDF, and an eTOC
delivered to individual subscribers’ inboxes.
• Each issue contains a timely, comprehensive and understandable analysis of the most commercially
promising new life science and technology:
• The BioCentury Innovations editorial team selects from hundreds of scientific papers, news items and
other sources of information each week to distill the most important developments, and presents the
intelligence in three essential formats: Analysis, Translation in Brief and Distillery.
ANALYSIS: Provides an in-depth review of new
research findings and an essential understanding
of the commercial impact and next steps required
to transform the developments into commercial
value. Interviews with leading experts go beyond
the basic science to analyze and identify these
crucial next steps and the impact of these
findings on the players in the field.
DISTILLERY: Filters and classifies the most
important
current
research
papers
in
biotechnology, life sciences and chemistry and is
also organized to enable the reader to quickly
find articles of primary interest:
The analysis contains high-quality graphics and
tables laying out the science and the
competitive space and highlights the key areas
of targets and mechanisms, markers, drug
platforms, tools and the public-private interface.
• Techniques focuses on novel findings relevant
to research tools, disease models and
manufacturing processes that have the
potential to enable or improve drug discovery
and development.
• Therapeutics includes important research on
targets and compounds grouped by disease
class and indication.
TRANSLATION IN BRIEF: Provides short-form
items of key breakthroughs, new public-private
partnerships or emerging technologies that
allow readers to keep abreast of important
developments in translational research.
China 3%
Japan 4%
RoW
10%
Rest of
Europe
10%
U.S. 60%
U.K./Germany/
France
13%
Regions where Distillery Items Originate
BioCentury Innovations evaluates about
14,000 articles a year and selects less than
7% for its Distillery section.
BioCentury®; The BioCentury 100™; The Clear Route to ROI™, Because Real Intelligence is Hard to Find™, BCIQ™, BioPharma’s Knowledge Center™ and BioCentury Innovations™
are trademarks of BIOCENTURY PUBLICATIONS, INC. Copyright© 2015 ALL RIGHTS RESERVED.